Quarterly report · Q2
4626.TEDINET S100PGNK
Period2022-04-01 → 2022-09-30
Filed2022-11-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥52.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥98.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥48.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥10.5bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥9.3bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥10.2bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥18.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.5bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥10.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥9.5bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥7.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥6.8bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥198.4bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥189.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥184.0bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥105.0bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥103.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥93.4bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥85.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥81.5bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥57.3bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥51.6bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥57.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥51.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥51.6bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥54.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥12.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥18.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥11.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥11.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥133.32 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.86 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.13 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥118.84 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.83 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 47.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.1% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥1.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥142m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥30m |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥38.7bn |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥38.7bn |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥10.4bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.0bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥51.1bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥51.1bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥11.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥52.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥52.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥142m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥11.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥1.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥54m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥6m |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥34.9bn |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥34.9bn |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥8.3bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥11.8bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥11.8bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.5bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥46.6bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥46.6bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥9.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥48.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥48.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥54m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥9.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 506
| Item | Context | Value | Unit |
|---|---|---|---|
| Raw materials and supplies | CurrentQuarterInstant | 6418000000 | JPY |
| Other ca | Prior1YearInstant | 3397000000 | JPY |
| Other ca | CurrentQuarterInstant | 3556000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -131000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -115000000 | JPY |
| Current assets | Prior1YearInstant | 98766000000 | JPY |
| Current assets | CurrentQuarterInstant | 105380000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 20567000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 20349000000 | JPY |
| Other net ppe | Prior1YearInstant | 31688000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 35152000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 52255000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 55501000000 | JPY |
| Goodwill | Prior1YearInstant | 5972000000 | JPY |
| Goodwill | CurrentQuarterInstant | 5762000000 | JPY |
| Sales rights ia | Prior1YearInstant | 17483000000 | JPY |
| Sales rights ia | CurrentQuarterInstant | 16659000000 | JPY |
| Customer related assets ia | Prior1YearInstant | 5952000000 | JPY |
| Customer related assets ia | CurrentQuarterInstant | 5714000000 | JPY |
| Other ia | Prior1YearInstant | 2650000000 | JPY |
| Other ia | CurrentQuarterInstant | 2784000000 | JPY |
| Intangible assets | Prior1YearInstant | 32058000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 30920000000 | JPY |
| Other ioa | Prior1YearInstant | 6366000000 | JPY |
| Other ioa | CurrentQuarterInstant | 6793000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -174000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -186000000 | JPY |
| Investments and other assets | Prior1YearInstant | 6192000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 6607000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 90507000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 93028000000 | JPY |
| Assets | Prior1YearInstant | 189273000000 | JPY |
| Assets | CurrentQuarterInstant | 198409000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 9255000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 8727000000 | JPY |
| Short term loans payable | Prior1YearInstant | 13232000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 12908000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 16537000000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 17346000000 | JPY |
| Income taxes payable | Prior1YearInstant | 2541000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 2800000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 1308000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 1214000000 | JPY |
| Other provision cl | Prior1YearInstant | 82000000 | JPY |
| Other provision cl | CurrentQuarterInstant | 407000000 | JPY |
| Other cl | Prior1YearInstant | 6443000000 | JPY |
| Other cl | CurrentQuarterInstant | 5930000000 | JPY |
| Current liabilities | Prior1YearInstant | 49403000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 49335000000 | JPY |
| Long term loans payable | Prior1YearInstant | 48383000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |